CAPRICOR THERAPEUTICS, INC. (CAPR) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US14070B3096
CAPRICOR THERAPEUTICS, INC. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 0.00 USD |
| Operating income | -108.14 m USD |
| EBIT | -108.25 m USD |
| Net income | -105.04 m USD |
| Diluted EPS – continuing operations | -2.26 USD |
Full history since 1999, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About CAPRICOR THERAPEUTICS, INC.
Capricor Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs in the United States. Its lead product candidate is the Deramiocel, an allogeneic cardiosphere-derived cells, which is in phase 3 clinical trial for the treatment of DMD. The company also develops Exosome protein-based vaccine, which is in preclinical trial to treat SARS-CoV-2; StealthX Exosome Platform, and exosome platform program consists of engineered exosomes for vaccine and therapeutic development and is in preclinical trial. In addition, it engages in developing StealthX, an engineered exosome-based vaccine candidate, under phase 1 clinical study for a range of therapeutic applications, including targeted RNA, protein, and small molecule therapeutics to treat or prevent a variety of diseases; It has license agreement with Johns Hopkins University, University of Rome License, and Cedars-Sinai Medical Center to develop and commercialize licensed products and licensed services under the licensed patent rights in all fields and a nonexclusive right to the know-how; Cell Line License Agreement with Life Technologies for the development of exosomes platform. The company was founded in 2005 and is headquartered in San Diego, California.
More stocks
- GRAY MEDIA, INC (GTN-A)
- Henan Taloph Pharmaceutical Stock Co Ltd (600222.SS)
- China Haisum Engineering Co Ltd (002116.SZ)
- Shandong Astro-century Education&Technology Co Ltd (300654.SZ)
- Angel Studios, Inc. (ANGX)
- Hamaton Automotive Technology Co Ltd (300643.SZ)
- Anhui Deli Household Glass Co Ltd (002571.SZ)
- Stratasys Ltd (SSYS)
- Gulf Keystone Petroleum Ltd (GKP.L)
- Australian Agricultural Company Ltd (AAC.AX)
- Zhangjiagang Guangda Special Material Co Ltd (688186.SS)
- CRAWFORD & CO (CRD-B)
Not investment advice. All data without warranty, price as of 09.11.2026. Details in the risk notice.